Pramiracetam

company's website

Pramiracetam is a central nervous system stimulant and nootropic agent belonging to the racetam family of drugs. It is marketed by Menarini under the brand name Pramistar as a treatment for memory and attention deficits in aging people with neurodegenerative and vascular dementias in Italy and some Eastern European countries.

Details

Product Name: Pramiracetam
Chemical name: N-(2 - (bis isopropylamino) ethyl) -2 - oxo-1 - pyrrolidineacetamide
Purity: 99%
Molecular formula: C14H27N3O2
CAS No. :68497 -62-1
Physical Properties: white crystalline powder.
Chemical properties: high efficiency, low toxicity, good knowledge tolerated activator,
Uses: This product is an analog of piracetam, a new pyrrolidone brain function improving agent for the treatment of memory dysfunction and recognition, language barriers. Senile dementia (Alzheimer's disease) treatment and prevention.

Item		Specification	Result	Test Method
Active Ingredeints
Assay(As Dried Base,%)		98.5% to 101%	99.68%	HPLC
Physical Control
Appearance		Crystalline Powder	Complies	Visual
Color		White to Colourless	Complies	Visual
Odor &Taste		Characteristic	Complies	Organoleptic
Identification		Positive	Complies	IR&1H NMR
Loss on Drying		≤1.0%	0.35%	USP
Melting point		97°C-98°C	97°C-98°C	USP
Residue on ignition		≤0.5%	0.08%	USP
Chemical Control
Heavy metals (As Pb)		NMT20PPM	Conforms	USP
Related substance		Meet the requirements	Conforms	USP
Packing and Storage
Packing	Pack in paper-drums and two plastic-bags inside. 25kg/drum
Storage	Store in a well-closed container away from moisture and direct sunlight.
Shelf Life	3 years if sealed and stored properly.

my contact information is: 
Email: cloris_2016@tuskwei.com
SKYPPE: betty_3451
Website: http://www.tuskwei.net/

Coluracetam

company's website

Coluracetam (INN) (code name BCI-540; formerly MKC-231) is a nootropic agent of the racetam family. It was initially developed and tested by the Mitsubishi Tanabe Pharma Corporation for Alzheimer's disease. After the drug failed to reach endpoints in its clinical trials it was in-licensed by BrainCells Inc for investigations into major depressive disorder (MDD), which was preceded by being awarded a "Qualifying Therapeutic Discovery Program Grant" by the state of California. Findings from phase IIa clinical trials have suggested that it would be a potential medication for comorbid MDD with generalized anxiety disorder (GAD). BrainCells Inc is currently[when?] out-licensing the drug for this purpose. [full citation needed] It may also have potential use in prevention and treatment of ischemic retinopathy and retinal and optic nerve injury.

Product Description

Coluracetam      135463-81-9

 

Product Name: Coluracetam MKC-231

Chemical Name: N-(2,3-Dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide

CAS No.: 135463-81-9

Formula: C19H23N3O3

Purity:99%

Molecular Weight:341.40

Appearance:white crystal powder

Boiling Point:634.1°C at 760 mmHg °C

Description: Coluracetam (BCI-540) is a nootropic drug of the racetam family

Application:mainly applied to promote intellectual product. /raw material used in Synthesis/ pharmaceutical raw material and for research

 

Specification:

 

Name:  Coluracetam

CAS:   135463-81-9

Purity:99

Chemical name	Coluracetam
CAS No.	135463-81-9
Synonym	Coluracetam
Molecular Formula	C19H23N3O3
Other name	MKC-231
Store at	Room temperature
Purity	99% min
Appearance	White to off white powder

Main Function:

· Improved Memory

· Increased Learning Ability

· Improved Cognitive Processing

· Heightened Reflexes

· Heightened Perception

· Reduced Anxiety

· Reduced Depression

my contact information is: 
Email: cloris_2016@tuskwei.com 
SKYPPE: betty_3451
Website: http://www.tuskwei.net/